Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: CUBBY who wrote (2682)	7/13/1999 8:38:00 AM
From: Joe	Read Replies (1) \| Respond to of 4140

Cubby, this is big. Optimaster? For the newbies, this is really big. This is the only vision correction procedure the FDA has ever allowed both eyes to be treated on the same day in clinical trials. And this is the second time they granted it to Sunrise. What I'm talking about is the patient's total vision. If their were any question about safety, even the slightest question, FDA would not have granted this approval. This is big. Joe